Recent AQST News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 12:56:17 PM
- Aquestive Therapeutics to Hold Virtual Investor Day to Provide Pipeline Updates on September 27th • GlobeNewswire Inc. • 09/09/2024 12:15:00 PM
- Aquestive Therapeutics to Participate in Two Upcoming Investor Conferences • GlobeNewswire Inc. • 08/22/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 12:08:37 PM
- Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates Expected Timing for NDA Filing of Anaphylm™ • GlobeNewswire Inc. • 08/14/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 06:45:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:26:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:24:46 PM
- Aquestive Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/06/2024 08:22:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 12:16:24 PM
- Aquestive Therapeutics Reports Positive Topline Data for Anaphylm™ (epinephrine) Sublingual Film from Self-Administration Study • GlobeNewswire Inc. • 07/25/2024 12:00:00 PM
- Aquestive Therapeutics to Report Second Quarter 2024 Financial Results and Recent Business Highlights on August 6 and Host Conference Call on August 7 at 8:00 a.m. ET • GlobeNewswire Inc. • 07/23/2024 12:00:00 PM
- Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism • GlobeNewswire Inc. • 06/27/2024 12:00:00 PM
- Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film • GlobeNewswire Inc. • 06/25/2024 12:00:00 PM
- Aquestive Therapeutics to Join the Russell 3000® and Russell 2000® Indexes Effective June 28, 2024 • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- Form 3/A - Initial statement of beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 06/12/2024 09:14:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 04:36:13 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 04:35:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 12:13:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:05:52 PM
- Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities • GlobeNewswire Inc. • 06/03/2024 12:00:00 PM
- Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharmacodynamic Data At 2024 Eastern Allergy Conference • GlobeNewswire Inc. • 05/28/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 05:40:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 05:40:07 PM
- Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference • GlobeNewswire Inc. • 05/09/2024 12:00:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM